CN105116076A - Method for detecting cefodizime sodium related substances - Google Patents

Method for detecting cefodizime sodium related substances Download PDF

Info

Publication number
CN105116076A
CN105116076A CN201510624851.8A CN201510624851A CN105116076A CN 105116076 A CN105116076 A CN 105116076A CN 201510624851 A CN201510624851 A CN 201510624851A CN 105116076 A CN105116076 A CN 105116076A
Authority
CN
China
Prior art keywords
cefodizime sodium
cefodizime
mobile phase
solution
related substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510624851.8A
Other languages
Chinese (zh)
Other versions
CN105116076B (en
Inventor
陈学文
沈灏
华军杰
朱炜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Erye Pharmaceutical Co Ltd
Original Assignee
Suzhou Erye Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Erye Pharmaceutical Co Ltd filed Critical Suzhou Erye Pharmaceutical Co Ltd
Priority to CN201510624851.8A priority Critical patent/CN105116076B/en
Publication of CN105116076A publication Critical patent/CN105116076A/en
Application granted granted Critical
Publication of CN105116076B publication Critical patent/CN105116076B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The invention relates to a method for detecting cefodizime sodium related substances. Ammonium dibasic phosphate and acetonitrile are served as mobile phases to perform gradient elution; and cefodizime can be effectively separated from the related substances.

Description

A kind of detection method of Cefodizime Sodium related substance
Technical field
The present invention relates to a kind of detection method of Cefodizime Sodium related substance.
Background technology
Cefodizime Sodium (cefodizime) is as third-generation cephalosporin, in the world first by German HoechstRoussel Developed, go through in Japan's listing (trade name: Neucef) in nineteen ninety, within 1994, go through in importer, domestic and international clinical practice has the history of nearly 20 years.
The known at present impurity of this product is: 2-sulfydryl-4-methyl-5-thiazole acetic acid (related substance I) and Δ-2 Cefodizime (related substance II).
The existing liquid phase testing conditions of Cefodizime Sodium is mixed into mobile phase with 920:80, isocratic elution with phosphate buffer (get potassium dihydrogen phosphate 0.87g and ADSP 0.22g, be dissolved in water and be diluted to 1000ml, shaking up) and acetonitrile.Though the method can realize effectively being separated of Cefodizime and related substance, be difficult to tackle the separation of complicated ingredient under the accelerated test conditions such as acid, alkali, high temperature.
Summary of the invention
The present invention relates to a kind of new method that Cefodizime Sodium related substance is detected:
Need testing solution: get cefodizime sodium for injection appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Time/min Mobile phase A (%) Mobile phase B (%)
0 95 5
15 80 20
20 80 20
25 95 5
30 95 5
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
Adopt detection method of the present invention can realize effectively being separated of Cefodizime Sodium and related substance I, related substance II and trans Cefodizime, degree of separation is good, and has good reappearance.
Accompanying drawing explanation
Fig. 1 adopts detection method of the present invention Cefodizime Sodium to be detected to the liquid chromatogram obtained.
Embodiment
Need testing solution: get cefodizime sodium for injection appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Time/min Mobile phase A (%) Mobile phase B (%)
0 95 5
15 80 20
20 80 20
25 95 5
30 95 5
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
Differentiated by the ownership of internal standard method to impurity peaks, result is as follows:
Synergy RT Content (%)
2-sulfydryl-4-methyl-5-thiazole acetic acid 3.280 0.11
Δ-2 Cefodizime 6.477 0.03
Cefodizime 7.267 99.6
Trans Cefodizime 10.460 0.06

Claims (2)

1. a detection method for Cefodizime Sodium related substance, is characterized in that:
Need testing solution: get cefodizime sodium for injection powder appropriate, dissolves with water for injection and is quantitatively diluted to the solution of 0.5mg/ml;
Mobile phase A: 5mmol/L ammonium dibasic phosphate solution;
Mobile phase B: acetonitrile;
Chromatographic column: 200mm × 4.6mm, 5 μm;
Filler: C18 alkyl silane bonded silica gel;
Column temperature: 25 DEG C;
Determined wavelength: 262nm;
Flow velocity: 1.0mL/min;
Condition of gradient elution:
Get above-mentioned need testing solution 20 μ l, inject high performance liquid chromatograph, record chromatogram.
2. the detection method of Cefodizime Sodium according to claim 1, is characterized in that: differentiated by the ownership of internal standard method to impurity peaks, result is as follows:
CN201510624851.8A 2015-09-28 2015-09-28 A kind of detection method of Cefodizime Sodium about material Active CN105116076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510624851.8A CN105116076B (en) 2015-09-28 2015-09-28 A kind of detection method of Cefodizime Sodium about material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510624851.8A CN105116076B (en) 2015-09-28 2015-09-28 A kind of detection method of Cefodizime Sodium about material

Publications (2)

Publication Number Publication Date
CN105116076A true CN105116076A (en) 2015-12-02
CN105116076B CN105116076B (en) 2017-06-30

Family

ID=54664116

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510624851.8A Active CN105116076B (en) 2015-09-28 2015-09-28 A kind of detection method of Cefodizime Sodium about material

Country Status (1)

Country Link
CN (1) CN105116076B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109900812A (en) * 2017-12-07 2019-06-18 北京济美堂医药研究有限公司 Cefixime and its detection method in relation to substance
CN112067709A (en) * 2020-07-03 2020-12-11 海口市制药厂有限公司 Method for determining cefodizime sodium related substance for injection and application
WO2022247200A1 (en) * 2021-05-28 2022-12-01 海南海灵化学制药有限公司 Method for detecting impurities in latamoxef sodium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014107536A1 (en) * 2013-01-04 2014-07-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN104165949A (en) * 2014-08-29 2014-11-26 四川制药制剂有限公司 Inspection method for cefodizime sodium polymer for injection
CN104215714A (en) * 2014-09-21 2014-12-17 四川制药制剂有限公司 Determination method of related substance of cefodizime sodium for injection

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014107536A1 (en) * 2013-01-04 2014-07-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CN104165949A (en) * 2014-08-29 2014-11-26 四川制药制剂有限公司 Inspection method for cefodizime sodium polymer for injection
CN104215714A (en) * 2014-09-21 2014-12-17 四川制药制剂有限公司 Determination method of related substance of cefodizime sodium for injection

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
TERUYOSHI MARUNAKA 等: "Acidic degradation of cefodizime(THR-221) and structural elucidation of the products.I", 《CHEM.PHARM.BULL.》 *
刘雁鸣 等: "HPLC-DAD法对注射用头孢地嗪钠杂质谱的一致性分析研究", 《中国药品标准》 *
姜晓峰 等: "头孢地嗪钠含量和有关物测定方法研究", 《食品与药品》 *
钟莹 等: "HPLC梯度洗脱法测定注射用头孢地嗪钠的有关物质", 《中国抗生素杂志》 *
黄秀芬 等: "注射用头孢地嗪钠中特定杂质巯噻唑酸的含量测定", 《今日药学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109900812A (en) * 2017-12-07 2019-06-18 北京济美堂医药研究有限公司 Cefixime and its detection method in relation to substance
CN112067709A (en) * 2020-07-03 2020-12-11 海口市制药厂有限公司 Method for determining cefodizime sodium related substance for injection and application
WO2022247200A1 (en) * 2021-05-28 2022-12-01 海南海灵化学制药有限公司 Method for detecting impurities in latamoxef sodium

Also Published As

Publication number Publication date
CN105116076B (en) 2017-06-30

Similar Documents

Publication Publication Date Title
Blankenburg et al. Improving proteome coverage for small sample amounts: an advanced method for proteomics approaches with low bacterial cell numbers
CN104237421B (en) A kind of relevant substance detecting method of succinum love song Ge Lieting and preparation thereof
CN105651871A (en) Determination method of rivaroxaban and related substances
Zhang et al. Determination of eight quinolones in milk using immunoaffinity microextraction in a packed syringe and liquid chromatography with fluorescence detection
CN105116076A (en) Method for detecting cefodizime sodium related substances
Fan et al. Extraction and purification of capsaicin from capsicum oleoresin using an aqueous two-phase system combined with chromatography
CN107238672A (en) The content assaying method of impurity in a kind of isoniazid or its pharmaceutical composition
Dong et al. Isolation of immunoglobulin G from bovine milk whey by poly (hydroxyethyl methacrylate)‐based anion‐exchange cryogel
Correia et al. Recovery of biological active catechol‐O‐methyltransferase isoforms from Q‐sepharose
CN105301159A (en) High performance liquid chromatography analysis method of sirolimus
CN106770849B (en) A kind of detection method measuring doxercalciferol and its impurities
CN105467021A (en) Method for separation determination of related substances in bulk drugs and preparations of paricalcitol through HPLC method
CN101929988B (en) Method for detecting febuxostat-associated matters by using high performance liquid chromatography
Wang et al. An enzyme-assisted and nitrogen-blowing salt-induced solidified floating organic droplet microextraction for determination of clenbuterol and ractopamine in swine feed via capillary electrophoresis
CN102384946B (en) By the method for high efficiency liquid chromatography for separating and determining Entecavir and diastereo-isomerism thereof
CN104784972A (en) Preparation method and application of hesperidin immunoaffinity column
CN104535688B (en) A kind of assay method of Sustained Release Ambroxol Hydrochloride Capsules release
CN104122361B (en) Utilize the method for the beautiful more soft capsule of efficient liquid phase chromatographic analysis ammonia
CN107589212A (en) A kind of detection method of amoxil capsule about material
CN104764840A (en) Method for separating and detection palonosetron hydrochloride and impurity
CN102901783A (en) Content determination method for pranoprofen eye drops
CN106018573A (en) Method for detecting purity of tipiracil hydrochloride in TAS-102
CN103012435A (en) Cefodizime sodium preparation method
CN110907582A (en) Method for detecting celecoxib-related impurities and application thereof
CN101464432B (en) Method for measuring Cidofovir related substance by high efficiency liquid chromatography

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant